- Home
- SYRE vs MTN Comparison
SYRE vs MTN Comparison
Compare SYRE & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | MTN |
|---|---|---|
| Founded | 2013 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.6B |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SYRE | MTN |
|---|---|---|
| Price | $64.21 | $129.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $77.78 | ★ $165.50 |
| AVG Volume (30 Days) | ★ 898.2K | 726.4K |
| Earning Date | 05-07-2026 | 03-09-2026 |
| Dividend Yield | N/A | ★ 6.82% |
| EPS Growth | N/A | ★ 24.05 |
| EPS | N/A | ★ 0.65 |
| Revenue | N/A | ★ $2,964,347,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.44 |
| P/E Ratio | ★ N/A | $200.40 |
| Revenue Growth | N/A | ★ 2.74 |
| 52 Week Low | $12.04 | $123.82 |
| 52 Week High | $75.00 | $175.51 |
Technical Indicators
Market Signals| Indicator | SYRE | MTN |
|---|---|---|
| Relative Strength Index (RSI) | 80.96 | 45.41 |
| Support Level | $15.23 | $124.78 |
| Resistance Level | N/A | $145.92 |
| Average True Range (ATR) | 4.11 | 4.27 |
| MACD | 1.44 | 0.23 |
| Stochastic Oscillator | 66.69 | 46.69 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About MTN Vail Resorts Inc.
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.